TABLE 1.
2019 (n = 283) | 2020 (n = 277) | |
---|---|---|
Age, mean ± SD, y | 56.0 ± 19.0 | 56.5 ± 17.7 |
Sex, n (%) | ||
Female | 198 (70.0) | 203 (73.3) |
Male | 85 (30.0) | 74 (26.7) |
Race, n (%) | ||
Black | 256 (90.5) | 255 (92.1) |
White | 21 (7.4) | 12 (4.3) |
Asian | 2 (0.7) | 4 (1.4) |
Hispanic | 0 (0.0) | 1 (0.4) |
Undisclosed | 4 (1.4) | 5 (1.8) |
Comorbidities, n (%) | ||
Hypertension | 173 (61.1) | 163 (58.8) |
Diabetes mellitus | 96 (33.9) | 96 (34.7) |
Hyperlipidemia | 95 (33.6) | 74 (26.7) |
Asthma | 64 (22.6) | 48 (17.3) |
Heart failure | 29 (10.2) | 19 (6.9) |
CAD | 26 (9.2) | 19 (6.9) |
COPD | 21 (7.4) | 15 (5.5) |
Cancer | 21 (7.4) | 17 (6.1) |
Renal disease | 18 (6.4) | 24 (8.7) |
Type of visit, n (%) | ||
In-person | 277 (97.9) | 102 (36.8) |
Telehealth* | 6 (2.1) | 175 (63.2) |
*Telehealth visits included televideo and audio-only visits.
CAD indicates coronary artery disease; COPD, chronic obstructive pulmonary disease.